Skip to main content
Clinical Trials/NCT06220825
NCT06220825
Recruiting
N/A

PRactice of VENTilation in Critically Ill PEDiatric Patients (PRoVENT-PED) - an International Multicenter Observational Study

University Medical Center Groningen1 site in 1 country2,500 target enrollmentApril 1, 2024

Overview

Phase
N/A
Intervention
Not specified
Conditions
Critical Illness
Sponsor
University Medical Center Groningen
Enrollment
2500
Locations
1
Primary Endpoint
Peak inspiratory pressure
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

The goal of this worldwide observational study is to investigate ventilation practice in critically ill pediatric patients. The main questions it aims to answer are:

  1. What is the global current practice of ventilatory support in critically ill pediatric patients?
  2. Which potentially modifiable factors related to ventilation are associated with outcome? Participating pediatric intensive care units will gather detailed information about ventilation practice and outcome, such as duration of ventilatory support, length of ICU stay and ICU mortality.

Detailed Description

Rationale: Studies on ventilatory support in critically ill pediatric patients remain scarce and much of the current clinical practice is based upon experience and data originating from critically ill adult patients. Objectives: 1. To describe the worldwide practice of ventilatory support in critically ill pediatric patients; and 2. To identify potentially modifiable ventilation parameters that have independent associations with outcome. Hypothesis: 1. Practice of ventilatory support in critically ill pediatric patients varies substantially worldwide; and 2. Potentially modifiable factors related to ventilation have independent associations with outcome in critically ill pediatric patients. Study design: International, multicenter, observational cohort study in critically ill pediatric patients. Each year, data will be collected in two predefined 4-week periods, one in the winter season and one in the summer season. A third 4-week period will be in case of epi- or pandemics. The study is designed to run for 10 years; within these 10 years, there will be subprojects during pre-defined periods. Centers have the option to opt out during certain time periods to make the study manageable for every participating country/center. Study population: Critically ill pediatric patients (aged 0-18) admitted to the pediatric intensive care unit (PICU) and necessitating ventilatory support \> 12 hours. Premature infants will be excluded. Nature and extent of the burden and risks associated with participation, benefit and group relatedness: Because of the observational design of the study using routinely collected data, there is no additional burden for the patient. Collection of data from ICU charts or electronic medical records systems is of no risk to the patients.

Registry
clinicaltrials.gov
Start Date
April 1, 2024
End Date
April 1, 2034
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Expected use of (non-)invasive respiratory support for at least 12 hrs

Exclusion Criteria

  • premature infants (i.e., postconceptional age corrected for gestational age \< 40 weeks)

Outcomes

Primary Outcomes

Peak inspiratory pressure

Time Frame: First four days of (non-)invasive respiratory support

Peak inspiratory pressure

Plateau pressure

Time Frame: First four days of (non-)invasive respiratory support

Pateau pressure

Driving pressure

Time Frame: First four days of (non-)invasive respiratory support

Driving pressure

Mechanical power

Time Frame: First four days of (non-)invasive respiratory support

Mechanical power

Positive end-expiratory pressure

Time Frame: First four days of (non-)invasive respiratory support

Positive end-expiratory pressure

Tidal volume

Time Frame: First four days of (non-)invasive respiratory support

Tidal volume

Secondary Outcomes

  • Duration of respiratory support (in days)(Up to 28 days following initiation of (non-)invasive respiratory support)
  • ICU mortality(Up to 28 days following initiation of (non-)invasive respiratory support)
  • Ventilator-free days at day 28(Up to 28 days following initiation of (non-)invasive respiratory support)
  • Length of ICU stay (in days)(PICU admission)
  • PARDS prevalence(First four days of (non-)invasive respiratory support)

Study Sites (1)

Loading locations...

Similar Trials